News

Customer Stories

About Us

Contacts

STARLIMS Announces Public Offering in

the United States

HOLLYWOOD, Fla., May 23 -- STARLIMS Technologies Ltd. (Nasdaq: LIMS) today announced the pricing of a public offering of 2,100,000 of its ordinary shares at a price to the public of $13.50 per share. All of such ordinary shares are being sold by STARLIMS. The underwriters have been granted an option for a period of 30 days to purchase up to an additional 315,000 ordinary shares from STARLIMS to cover over-allotments, if any. Net proceeds to STARLIMS from the offering are expected to be approximately $25.5 million.

Oppenheimer & Co. is acting as Sole Bookrunning Manager of the offering and JMP Securities LLC is acting as co-lead manager of the offering. This offering of ordinary shares is being made only by means of a prospectus. Copies of the final prospectus may be obtained from Oppenheimer & Co. Inc. at 125 Broad Street, 16th Floor, New York, New York 10004 and JMP Securities LLC at 600 Montgomery Street, Suite 1100, San Francisco, California 94111.

These securities are being issued pursuant to a registration statement on Form F-1 promulgated under the Securities Act of 1933, as amended, which was filed with and declared effective by the Securities and Exchange Commission.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

STARLIMS is a leading provider of laboratory information management systems (LIMS), with over 20 years of LIMS experience. The company's flagship product, STARLIMS®, improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With operations in the United States, Israel, Canada, the United Kingdom and Hong Kong, the company serves over 500 customers in 40 countries. The Company's ordinary shares are also traded on the Tel Aviv Stock Exchange.